Uveal melanoma
|
disease |
Neoplasms; Eye Diseases
|
Neoplastic Process
|
376
|
22
|
0.050 |
None |
1.000 |
5 |
|
1993 |
2010 |
Melanoma, B16
|
disease |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
157
|
1
|
0.050 |
None |
1.000 |
5 |
|
1988 |
2018 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.050 |
None |
1.000 |
5 |
|
1996 |
2014 |
Amelanotic Skin Melanoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
13
|
|
0.050 |
None |
1.000 |
5 |
|
1993 |
2012 |
Chloasma
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
25
|
|
0.040 |
None |
1.000 |
4 |
|
2017 |
2019 |
Albinism, Ocular
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Eye Diseases; Skin and Connective Tissue Diseases
|
Congenital Abnormality
|
37
|
10
|
0.140 |
None |
1.000 |
4 |
6
|
2008 |
2017 |
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.340 |
None |
1.000 |
4 |
|
1991 |
2001 |
leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
2111
|
144
|
0.040 |
None |
1.000 |
4 |
|
1995 |
2019 |
Progressive Neoplastic Disease
|
phenotype |
|
Neoplastic Process
|
384
|
40
|
0.030 |
None |
1.000 |
3 |
|
1996 |
2008 |
Skin Pigmentation Disorder
|
group |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
21
|
|
0.030 |
None |
1.000 |
3 |
|
2017 |
2019 |
Kidney Failure, Acute
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
826
|
32
|
0.030 |
None |
1.000 |
3 |
|
2017 |
2018 |
Ocular albinism, type I
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Eye Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
38
|
24
|
0.030 |
None |
1.000 |
3 |
|
2011 |
2017 |
Childhood Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
1740
|
140
|
0.030 |
None |
1.000 |
3 |
|
1998 |
2019 |
Neurodegenerative Disorders
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
1515
|
85
|
0.030 |
None |
1.000 |
3 |
|
2018 |
2019 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.030 |
None |
1.000 |
3 |
|
2019 |
2019 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.030 |
None |
1.000 |
3 |
|
2001 |
2019 |
Hermanski-Pudlak Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Eye Diseases; Skin and Connective Tissue Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
70
|
59
|
0.030 |
None |
1.000 |
3 |
|
1999 |
2019 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.030 |
None |
1.000 |
3 |
|
2001 |
2019 |
Albinism, Tyrosinase-Negative
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Eye Diseases; Skin and Connective Tissue Diseases
|
Congenital Abnormality
|
2
|
|
0.310 |
None |
1.000 |
3 |
|
1989 |
1997 |
Metastatic Malignant Neoplasm in the Viscera
|
disease |
|
Neoplastic Process
|
30
|
2
|
0.030 |
None |
1.000 |
3 |
|
1996 |
2000 |
Squamous cell carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2507
|
257
|
0.110 |
None |
1.000 |
3 |
2
|
2009 |
2019 |
Basal cell carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
108
|
109
|
0.110 |
None |
1.000 |
3 |
1
|
2008 |
2019 |
Malignant neoplasm of skin
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
508
|
38
|
0.320 |
None |
1.000 |
3 |
1
|
2008 |
2011 |
Suntan
|
phenotype |
|
Organ or Tissue Function
|
53
|
94
|
0.100 |
None |
1.000 |
3 |
2
|
2009 |
2018 |
Progressive cGVHD
|
disease |
|
Disease or Syndrome
|
384
|
40
|
0.030 |
None |
1.000 |
3 |
|
1996 |
2008 |